[go: up one dir, main page]

NO20092960L - Krystallinsk minocycline base og framgangsmater for framstilling av denne - Google Patents

Krystallinsk minocycline base og framgangsmater for framstilling av denne

Info

Publication number
NO20092960L
NO20092960L NO20092960A NO20092960A NO20092960L NO 20092960 L NO20092960 L NO 20092960L NO 20092960 A NO20092960 A NO 20092960A NO 20092960 A NO20092960 A NO 20092960A NO 20092960 L NO20092960 L NO 20092960L
Authority
NO
Norway
Prior art keywords
minocycline base
processes
preparation
crystalline
crystalline minocycline
Prior art date
Application number
NO20092960A
Other languages
English (en)
Inventor
Zita Mendes
William Heggie
Susana Marto
Jose Rafael Antunes
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of NO20092960L publication Critical patent/NO20092960L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen framskaffer krystallinsk minosyklin-base. Der er særlig framskaffet tre krystallinske polymorfe former av minosyklin, benevnt som form I, form II og form III. Disse er karakterisert ved XRD og IR data. Framgangsmåter for framstilling av de nye polymorfe formene er også framskaffet. For eksempel blir form I framstilt ved å løse og/eller suspendere amorf minosyklin-base i et organisk løsningsmiddel valgt fra etere, etterfulgt av krystallisering fra blandingen.
NO20092960A 2007-02-23 2009-09-04 Krystallinsk minocycline base og framgangsmater for framstilling av denne NO20092960L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103661A PT103661B (pt) 2007-02-23 2007-02-23 Processo de preparação de minociclina base cristalina
PCT/GB2008/000625 WO2008102161A2 (en) 2007-02-23 2008-02-22 Crystalline minocycline base and processes for its preparation

Publications (1)

Publication Number Publication Date
NO20092960L true NO20092960L (no) 2009-11-20

Family

ID=39432804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092960A NO20092960L (no) 2007-02-23 2009-09-04 Krystallinsk minocycline base og framgangsmater for framstilling av denne

Country Status (20)

Country Link
US (2) US8258327B2 (no)
EP (1) EP2125705B1 (no)
JP (4) JP2010519247A (no)
KR (1) KR101391132B1 (no)
CN (1) CN101679218B (no)
AU (1) AU2008217619B2 (no)
BR (2) BR122021000846B1 (no)
CA (2) CA2835788C (no)
DK (1) DK2125705T3 (no)
ES (1) ES2610434T3 (no)
HU (1) HUE033030T2 (no)
IL (1) IL200544A0 (no)
MX (2) MX2009008980A (no)
NO (1) NO20092960L (no)
NZ (1) NZ579626A (no)
PL (1) PL2125705T3 (no)
PT (1) PT103661B (no)
RU (2) RU2485095C2 (no)
WO (1) WO2008102161A2 (no)
ZA (1) ZA200906517B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
PT104350A (pt) * 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
PT104644B (pt) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039637A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
PT106063B (pt) * 2011-12-19 2017-05-30 Inst Superior Tecnico Minociclina cristalina termorresistente produzida por recristalização com dióxido de carbono
CN104151186B (zh) * 2014-08-11 2016-06-15 重庆福安药业(集团)股份有限公司 替加环素杂质的立体选择性制备方法
PT108223B (pt) 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
KR20170134514A (ko) 2015-03-23 2017-12-06 바이오팜엑스 인코포레이티드 피부과 사용을 위한 약학 테트라사이클린 조성물
WO2017097891A1 (en) * 2015-12-10 2017-06-15 Sandoz Ag Crystalline eravacycline
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2021191273A1 (en) 2020-03-24 2021-09-30 Hovione Scientia Limited Compositions for use in treating meibomian gland dysfunction
WO2022043457A1 (en) 2020-08-27 2022-03-03 Hovione Scientia Limited Methods and compositions for treating rosacea
CN117105812B (zh) * 2023-08-16 2025-09-26 常州市第四制药厂有限公司 一种米诺环素无菌软膏剂及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US299111A (en) * 1884-05-27 Process of and apparatus
US3148212A (en) 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3526629A (en) * 1968-04-02 1970-09-01 American Cyanamid Co Beta-hydroxyethylpiperazinocarboxymethyl - 7 - dimethylamino - 6 - deoxy-6-demethyltetracycline
JPS5245716B1 (no) * 1970-07-10 1977-11-17
CA999855A (en) * 1972-09-18 1976-11-16 Societa' Farmaceutici Italia S.P.A. Process for the preparation of tetracyclines derivatives in the 7 position
CN85101404A (zh) * 1985-05-16 1987-01-17 帝人株式会社 头孢菌素衍生物的生产过程
JPH0737433B2 (ja) * 1987-06-11 1995-04-26 協和醗酵工業株式会社 ７−アミノ−６−デメチル−６−デオキシテトラサイクリンの製造法
US5202449A (en) * 1987-07-28 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline
US4918208A (en) * 1987-07-28 1990-04-17 Nippon Kayaku Kabushiki Kaisha Process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline
JPH04235188A (ja) * 1990-06-19 1992-08-24 Takeda Chem Ind Ltd ペネム化合物の結晶、その製造方法および抗菌剤
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja) * 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
DE69634054T2 (de) * 1995-07-17 2005-12-08 Warner-Lambert Co. Kristalline (R-(R*, R*))-2-(4-Fluorophenyl)-β, δ-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-((Phenylamino)Carbonyl)-1H-Pyrrol-1-Heptancarbonsäure Hemi Calcium Salz (Atorvastatin)
MY126580A (en) 1997-12-22 2006-10-31 Merck Sharp & Dohme Molecular dispersion composition with enchanced bioavailabity
AU1405600A (en) * 1998-12-01 2000-06-19 Atropos Limited A medical device comprising an evertable sleeve
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
AU2006272698B2 (en) 2005-07-21 2012-11-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina

Also Published As

Publication number Publication date
WO2008102161A3 (en) 2009-01-08
KR20100014520A (ko) 2010-02-10
CA2835788A1 (en) 2008-08-28
CA2722496A1 (en) 2008-08-28
RU2485095C2 (ru) 2013-06-20
CN101679218A (zh) 2010-03-24
NZ579626A (en) 2011-12-22
US20130030195A1 (en) 2013-01-31
JP2010519247A (ja) 2010-06-03
AU2008217619B2 (en) 2013-01-10
RU2009135403A (ru) 2011-03-27
MX2009008980A (es) 2009-11-11
CA2835788C (en) 2018-03-27
DK2125705T3 (en) 2017-01-16
EP2125705B1 (en) 2016-10-12
ES2610434T3 (es) 2017-04-27
JP2019142882A (ja) 2019-08-29
AU2008217619A1 (en) 2008-08-28
BRPI0807319A2 (pt) 2017-05-02
JP2014169319A (ja) 2014-09-18
RU2577331C2 (ru) 2016-03-20
RU2013112021A (ru) 2014-09-27
WO2008102161A2 (en) 2008-08-28
US20100286417A1 (en) 2010-11-11
BRPI0807319B1 (pt) 2021-08-10
CN101679218B (zh) 2013-10-30
MX340539B (es) 2016-07-13
HUE033030T2 (hu) 2017-11-28
PT103661A (pt) 2008-08-25
US8258327B2 (en) 2012-09-04
JP2017039742A (ja) 2017-02-23
WO2008102161A9 (en) 2008-11-13
EP2125705A2 (en) 2009-12-02
US9416097B2 (en) 2016-08-16
BR122021000846B1 (pt) 2021-08-10
PT103661B (pt) 2010-09-07
KR101391132B1 (ko) 2014-05-02
CA2722496C (en) 2014-06-10
IL200544A0 (en) 2010-05-17
PL2125705T3 (pl) 2017-02-28
ZA200906517B (en) 2010-09-29

Similar Documents

Publication Publication Date Title
NO20092960L (no) Krystallinsk minocycline base og framgangsmater for framstilling av denne
UA109883C2 (uk) Спосіб отримання сполук для застосування як інгібіторів sglt2
IN2012DN03176A (no)
PH12017500437A1 (en) Methods for synthesis of graphene derivatives and functional materials from asphaltenes, graphene derivatives, 2d materials and applications of use
WO2009053854A3 (en) Polymorphs of dasatinib and process for preparation thereof
WO2006027705A3 (en) Synthesis of triethylenetetramines
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
JP2012001634A5 (no)
Ribeiro et al. Efficient synthesis of spiroisoxazoline oxindoles
EA201000147A1 (ru) Способ выделения и очистки монтелукаста
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
AU2010271717A8 (en) Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
NO20080648L (no) Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium
WO2011069105A3 (en) Process for producing fermentation products and fermentation medium compositions therefor
Chong et al. DABCO-catalyzed synthesis of 3-bromo-/3-iodo-2H-pyrans from propargyl alcohols, dialkyl acetylene dicarboxylates, and N-bromo-/N-iodosuccinimides
RU2016134404A (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА α МОНОБЕНЗОАТА СОЕДИНЕНИЯ А, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЕ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
WO2007088558A3 (en) A process for purification of valsartan
NO20084414L (no) Fremgangsmate for fremstilling av heterocykliske derivater
WO2010140132A8 (en) Process for the preparation of crystalline aprepitant having form i content
WO2009022600A1 (ja) ヒドラジン化合物の製造方法、ならびにヒドラジン化合物の製造中間体およびその製造方法
WO2008113661A3 (en) Process for preparing substituted phenylhydrazines
WO2009010990A3 (en) Process for the preparation of o-desmethylvenlafaxine succinate polymorphic forms
WO2007054784A8 (en) An improved process for the preparation of granisetron hydrochloride
WO2011154586A3 (es) Procedimientos mejorados para la preparación de derivados de quinoxalina
WO2013131521A8 (en) Open-cage fullerenes and a method for preparing the same

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HOVIONE SCIENTIA LIMITED, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application